natgillin/translations-raw huggingface dataset:
89 Patients with high blood pressure and type 2 diabetes with kidney disease In patients with high blood pressure and type 2 diabetes, 300 mg (four tablets a day) once daily is the preferred maintenance dose for the treatment of associated kidney disease.
Bolniki z visokim krvnim tlakom in sladkorno boleznijo tipa 2 z boleznijo ledvic Priporočeni vzdrževalni odmerek za zdravljenje bolezni ledvic, povezane z visokim krvnim tlakom in sladkorno boleznijo tipa 2, je 300 mg (štiri tablete) enkrat na dan.
If you take more Irbesartan Winthrop than you should If you accidentally take too many tablets, contact your doctor immediately.
Če ste vzeli večji odmerek zdravila Irbesartan Winthrop, kot bi smeli Če ste pomotoma vzeli preveč tablet, se nemudoma posvetujte s svojim zdravnikom.
Children should not take Irbesartan Winthrop Irbesartan Winthrop should not be given to children under 18 years of age.
Otroci ne smejo jemati zdravila Irbesartan Winthrop Otroci in mladostniki, mlajši od 18 let, zdravila Irbesartan Winthrop ne smejo jemati.
If you forget to take Irbesartan Winthrop If you accidentally miss a daily dose, just take the next dose as normal.
Če ste pozabili vzeti zdravilo Irbesartan Winthrop Če ste pozabili vzeti dnevni odmerek, vzemite le naslednji predvideni odmerek ob običajnem času.
Like all medicines, Irbesartan Winthrop can cause side effects, although not everybody gets them.
Kot vsa zdravila ima lahko tudi zdravilo Irbesartan Winthrop neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
If you get any of these symptoms or get short of breath, stop taking Irbesartan Winthrop and contact your doctor immediately.
Če opazite kateregakoli od teh simptomov ali se pojavi občutek težkega dihanja, zdravilo Irbesartan Winthrop takoj prenehajte uporabljati in nemudoma poiščite zdravniško pomoč.
Side effects reported in clinical studies for patients treated with Irbesartan Winthrop were:
V kliničnih preskušanjih so pri bolnikih, ki so se zdravili z zdravilom Irbesartan Winthrop, poročali o naslednjih neželenih učinkih:
Some undesirable effects have been reported since marketing of Irbesartan Winthrop but the frequency for them to occur is not known.
90 Po prihodu zdravila Irbesartan Winthrop na tržišče so poročali še o nekaterih drugih neželenih učinkih, vendar pa njihova pogostnost ni znana.
HOW TO STORE IRBESARTAN WINTHROP
SHRANJEVANJE ZDRAVILA IRBESARTAN WINTHROP
Do not use Irbesartan Winthrop after the expiry date which is stated on the carton and on the blister after EXP.
Zdravila Irbesartan Winthrop ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli ali pretisnem omotu poleg oznake "Upor. do:".
What Irbesartan Winthrop contains The active substance is irbesartan.
Kaj vsebuje zdravilo Irbesartan Winthrop Zdravilna učinkovina je irbesartan.
Each tablet of Irbesartan Winthrop 75 mg contains 75 mg irbesartan.
Ena tableta zdravila Irbesartan Winthrop 75 mg vsebuje 75 mg irbesartana.
What Irbesartan Winthrop looks like and contents of the pack Irbesartan Winthrop 75 mg tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2771 engraved on the other side.
Na eni strani imajo vtisnjeno srce, na drugi pa vrezano številko 2771.
Irbesartan Winthrop 75 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Irbesartan Winthrop 75 mg tablete so na voljo v pretisnih omotih s 14, 28, 56 ali 98 tabletami.
92 Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51
93 Latvija sanofi- aventis Latvia SIA Tel: +371 67 33 24 51
INFORMATION FOR THE USER Irbesartan Winthrop 150 mg tablets irbesartan
94 NAVODILO ZA UPORABO Irbesartan Winthrop 150 mg tablete irbesartan
94 Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Uporaba drugih zdravil Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta.
Patients with high blood pressure The usual dose is 150 mg once a day.
96 Običajen odmerek je 150 mg enkrat na dan.
95 Patients with high blood pressure and type 2 diabetes with kidney disease In patients with high blood pressure and type 2 diabetes, 300 mg (two tablets a day) once daily is the preferred maintenance dose for the treatment of associated kidney disease.
Bolniki z visokim krvnim tlakom in sladkorno boleznijo tipa 2 z boleznijo ledvic Priporočeni vzdrževalni odmerek za zdravljenje bolezni ledvic, povezane z visokim krvnim tlakom in sladkorno boleznijo tipa 2, je 300 mg (dve tableti) enkrat na dan.
Some undesirable effects have been reported since marketing of Irbesartan Winthrop but the frequency for them to occur is not known.
97 Po prihodu zdravila Irbesartan Winthrop na tržišče so poročali še o nekaterih drugih neželenih učinkih, vendar pa njihova pogostnost ni znana.
Each tablet of Irbesartan Winthrop 150 mg contains 150 mg irbesartan.
Ena tableta zdravila Irbesartan Winthrop 150 mg vsebuje 150 mg irbesartana.
What Irbesartan Winthrop looks like and contents of the pack Irbesartan Winthrop 150 mg tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2772 engraved on the other side.
Na eni strani imajo vtisnjeno srce, na drugi pa vrezano številko 2772.
Irbesartan Winthrop 150 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Irbesartan Winthrop 150 mg tablete so na voljo v pretisnih omotih s 14, 28, 56 ali 98 tabletami.
INFORMATION FOR THE USER Irbesartan Winthrop 300 mg tablets irbesartan
101 NAVODILO ZA UPORABO Irbesartan Winthrop 300 mg tablete irbesartan
101 Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Uporaba drugih zdravil Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta.
Patients with high blood pressure The usual dose is 150 mg once a day.
103 Običajen odmerek je 150 mg enkrat na dan.
102 Patients with high blood pressure and type 2 diabetes with kidney disease In patients with high blood pressure and type 2 diabetes, 300 mg once daily is the preferred maintenance dose for the treatment of associated kidney disease.
Bolniki z visokim krvnim tlakom in sladkorno boleznijo tipa 2 z boleznijo ledvic Priporočeni vzdrževalni odmerek za zdravljenje bolezni ledvic, povezane z visokim krvnim tlakom in sladkorno boleznijo tipa 2, je 300 mg enkrat na dan.
Some undesirable effects have been reported since marketing of Irbesartan Winthrop but the frequency for them to occur is not known.
104 Po prihodu zdravila Irbesartan Winthrop na tržišče so poročali še o nekaterih drugih neželenih učinkih, vendar pa njihova pogostnost ni znana.
Each tablet of Irbesartan Winthrop 300 mg contains 300 mg irbesartan.
Ena tableta zdravila Irbesartan Winthrop 300 mg vsebuje 300 mg irbesartana.
What Irbesartan Winthrop looks like and contents of the pack Irbesartan Winthrop 300 mg tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2773 engraved on the other side.
Na eni strani imajo vtisnjeno srce, na drugi pa vrezano številko 2773.
Irbesartan Winthrop 300 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Irbesartan Winthrop 300 mg tablete so na voljo v pretisnih omotih s 14, 28, 56 ali 98 tabletami.
106 Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51
107 Latvija sanofi- aventis Latvia SIA Tel: +371 67 33 24 51
INFORMATION FOR THE USER Irbesartan Winthrop 75 mg film-coated tablets irbesartan
108 NAVODILO ZA UPORABO Irbesartan Winthrop 75 mg filmsko obložene tablete irbesartan
108 Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Uporaba drugih zdravil Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta.
Patients with high blood pressure The usual dose is 150 mg once a day (two tablets a day).
110 Običajen odmerek je 150 mg enkrat na dan (dve tableti).
109 Patients with high blood pressure and type 2 diabetes with kidney disease In patients with high blood pressure and type 2 diabetes, 300 mg (four tablets a day) once daily is the preferred maintenance dose for the treatment of associated kidney disease.
Bolniki z visokim krvnim tlakom in sladkorno boleznijo tipa 2 z boleznijo ledvic Priporočeni vzdrževalni odmerek za zdravljenje bolezni ledvic, povezane z visokim krvnim tlakom in sladkorno boleznijo tipa 2, je 300 mg (štiri tablete) enkrat na dan.
If you accidentally take too many tablets, contact your doctor immediately.
Če ste vzeli večji odmerek zdravila Irbesartan Winthrop, kot bi smeli Če ste pomotoma vzeli preveč tablet, se nemudoma posvetujte s svojim zdravnikom.
If you accidentally miss a daily dose, just take the next dose as normal.
Če ste pozabili vzeti zdravilo Irbesartan Winthrop Če ste pozabili vzeti dnevni odmerek, vzemite le naslednji predvideni odmerek ob običajnem času.
Some undesirable effects have been reported since marketing of Irbesartan Winthrop but the frequency for them to occur is not known.
111 Po prihodu zdravila Irbesartan Winthrop na tržišče so poročali še o nekaterih drugih neželenih učinkih, vendar pa njihova pogostnost ni znana.
What Irbesartan Winthrop looks like and contents of the pack Irbesartan Winthrop 75 mg film-coated tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2871 engraved on the other side.
Na eni strani imajo vtisnjeno srce, na drugi pa vrezano številko 2871.
Irbesartan Winthrop 75 mg film-coated tablets are supplied in blister packs of 14, 28, 56, 84 or 98 film-coated tablets.
Irbesartan Winthrop 75 mg filmsko obložene tablete so na voljo v pretisnih omotih s 14, 28, 56, 84 ali 98 filmsko obloženimi tabletami.
SANOFI SYNTHELABO LIMITED Edgefield Avenue - Fawdon Newcastle Upon Tyne, Tyne & Wear NE3 3TT - United Kingdom
112 SANOFI SYNTHELABO LIMITED Edgefield Avenue - Fawdon Newcastle Upon Tyne, Tyne & Wear NE3 3TT - Velika Britanija
SANOFI WINTHROP INDUSTRIE 30-36 Avenue Gustave Eiffel, BP 7166 F-37071 Tours Cedex 2 - France
SANOFI WINTHROP INDUSTRIE 30- 36 Avenue Gustave Eiffel, BP 7166 F- 37071 Tours Cedex 2 - Francija
112 Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51
114 Latvija sanofi- aventis Latvia SIA Tel: +371 67 33 24 51
INFORMATION FOR THE USER Irbesartan Winthrop 150 mg film-coated tablets irbesartan
115 NAVODILO ZA UPORABO Irbesartan Winthrop 150 mg filmsko obložene tablete irbesartan
114 Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Uporaba drugih zdravil Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta.
Patients with high blood pressure The usual dose is 150 mg once a day.
117 Običajen odmerek je 150 mg enkrat na dan.
115 Patients with high blood pressure and type 2 diabetes with kidney disease In patients with high blood pressure and type 2 diabetes, 300 mg (two tablets a day) once daily is the preferred maintenance dose for the treatment of associated kidney disease.
Bolniki z visokim krvnim tlakom in sladkorno boleznijo tipa 2 z boleznijo ledvic Priporočeni vzdrževalni odmerek za zdravljenje bolezni ledvic, povezane z visokim krvnim tlakom in sladkorno boleznijo tipa 2, je 300 mg (dve tableti) enkrat na dan.
Some undesirable effects have been reported since marketing of Irbesartan Winthrop but the frequency for them to occur is not known.
118 Po prihodu zdravila Irbesartan Winthrop na tržišče so poročali še o nekaterih drugih neželenih učinkih, vendar pa njihova pogostnost ni znana.
What Irbesartan Winthrop looks like and contents of the pack Irbesartan Winthrop 150 mg film-coated tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2872 engraved on the other side.
Na eni strani imajo vtisnjeno srce, na drugi pa vrezano številko 2872.
Irbesartan Winthrop 150 mg film-coated tablets are supplied in blister packs of 14, 28, 56, 84 or 98 film-coated tablets.
Irbesartan Winthrop 150 mg filmsko obložene tablete so na voljo v pretisnih omotih s 14, 28, 56, 84 ali 98 filmsko obloženimi tabletami.
SANOFI SYNTHELABO LIMITED Edgefield Avenue - Fawdon Newcastle Upon Tyne, Tyne & Wear NE3 3TT - United Kingdom
119 SANOFI SYNTHELABO LIMITED Edgefield Avenue - Fawdon Newcastle Upon Tyne, Tyne & Wear NE3 3TT - Velika Britanija
119 Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51
121 Latvija sanofi- aventis Latvia SIA Tel: +371 67 33 24 51
INFORMATION FOR THE USER Irbesartan Winthrop 300 mg film-coated tablets irbesartan
122 NAVODILO ZA UPORABO Irbesartan Winthrop 300 mg filmsko obložene tablete irbesartan
121 Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Uporaba drugih zdravil Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta.
Patients with high blood pressure The usual dose is 150 mg once a day.
124 Običajen odmerek je 150 mg enkrat na dan.
122 Patients with high blood pressure and type 2 diabetes with kidney disease In patients with high blood pressure and type 2 diabetes, 300 mg once daily is the preferred maintenance dose for the treatment of associated kidney disease.
Bolniki z visokim krvnim tlakom in sladkorno boleznijo tipa 2 z boleznijo ledvic Priporočeni vzdrževalni odmerek za zdravljenje bolezni ledvic, povezane z visokim krvnim tlakom in sladkorno boleznijo tipa 2, je 300 mg enkrat na dan.
Some undesirable effects have been reported since marketing of Irbesartan Winthrop but the frequency for them to occur is not known.
125 Po prihodu zdravila Irbesartan Winthrop na tržišče so poročali še o nekaterih drugih neželenih učinkih, vendar pa njihova pogostnost ni znana.
What Irbesartan Winthrop looks like and contents of the pack Irbesartan Winthrop 300 mg film-coated tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2873 engraved on the other side.
Na eni strani imajo vtisnjeno srce, na drugi pa vrezano številko 2873.
Irbesartan Winthrop 300 mg film-coated tablets are supplied in blister packs of 14, 28, 56, 84 or 98 film-coated tablets.
Irbesartan Winthrop 300 mg filmsko obložene tablete so na voljo v pretisnih omotih s 14, 28, 56, 84 ali 98 filmsko obloženimi tabletami.
SANOFI SYNTHELABO LIMITED Edgefield Avenue - Fawdon Newcastle Upon Tyne, Tyne & Wear NE3 3TT - United Kingdom
126 SANOFI SYNTHELABO LIMITED Edgefield Avenue - Fawdon Newcastle Upon Tyne, Tyne & Wear NE3 3TT - Velika Britanija
126 Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51
128 Latvija sanofi- aventis Latvia SIA Tel: +371 67 33 24 51
Iscover are pink tablets.
Zdravilo Iscover so tablete rožnate barve.
Iscover contains the active ingredient clopidogrel (75 mg).
Zdravilo Iscover vsebuje zdravilno učinkovino klopidogrel (75 mg).
Iscover is used in adult patients to prevent atherothrombotic events (problems caused by blood clots and hardening of arteries).
Zdravilo Iscover se uporablja pri odraslih bolnikih za preprečevanje aterotrombotičnih dogodkov (težav, ki jih povzročajo krvni strdki in otrdevanje krvnih žil).
Iscover can be given to: • patients who have recently had a myocardial infarction (heart attack); Iscover can be started in the few days after the attack and up to 35 days later, • patients who have had a recent ischaemic stroke (non-bleeding stroke); Iscover can be started in the 7 days after the attack and up to 6 months later, • patients with peripheral arterial disease (problem with blood flow in the arteries), • patients who have a condition known as acute coronary syndrome, when it should be given with aspirin (another anticoagulant), including patients who have had a stent inserted (a short tube placed in an artery to prevent it closing up).
Zdravilo Iscover se lahko daje: • bolnikom, ki so nedavno imeli miokardni infarkt (srčni napad); z jemanjem zdravila Iscover se lahko začne nekaj dni po napadu in do 35 dni po njem; • bolnikom, ki so nedavno imeli ishemično kap (kap zaradi žilne zapore); z jemanjem zdravila Iscover se lahko začne v 7 dneh po napadu in do 6 mesecev po njem; • bolnikom s periferno arterijsko boleznijo (težavami s pretokom krvi v arterijah); • bolnikom z akutnim koronarnim sindromom, pri katerih se mora zdravilo dajati skupaj z aspirinom (drugim antikoagulantom), vključno z bolniki, katerim je bil vstavljen stent (kratka cevka, nameščena v arteriji, da prepreči njeno zapiranje).
Iscover can be used in patients who are having a heart attack with an ‘ ST segment elevation’ (an abnormal reading on the electrocardiogram or ECG) when the doctor thinks that they would benefit from the treatment.
Zdravilo Iscover se lahko uporablja pri bolnikih, ki imajo srčni napad z „ elevacijo spojnice ST “ (nenormalni zapis na elektrokardiogramu ali EKG), če zdravnik meni, da bi zdravilo lahko bolniku pomagalo.
It can also be used in patients who do not have this abnormal reading on the ECG, if they have unstable angina (a severe type of chest pain) or have had a non-Q-wave myocardial infarction.
Lahko se uporablja tudi pri bolnikih, ki nimajo tega nenormalnega zapisa na EKG, če imajo nestabilno angino (resno obliko bolečine v prsih) ali so imeli miokardni infarkt brez Q zobca.
Iscover should be given as a single daily dose of 75 mg (one tablet) with or without food.
Iscover se daje kot enkratni dnevni odmerek 75 mg (ena tableta), z ali brez hrane.
In acute coronary syndrome, Iscover is used together with aspirin and the treatment generally starts with a 300 mg loading dose, which is followed by a daily dose of 75 mg for at least 4 weeks in ST elevation myocardial infarction or for up to 12 months in non-ST elevation syndrome.
Pri akutnem koronarnem sindromu se Iscover uporablja skupaj z aspirinom, zdravljenje pa se na splošno začne s 300 mg udarnim odmerkom, ki mu sledi jemanje 75 mg dnevnega odmerka v trajanju najmanj 4 tedne pri miokardnem infarktu z elevacijo spojnice ST ali največ 12 mesecev pri sindromu brez elevacije spojnice ST.
Iscover is an inhibitor of platelet aggregation.
Zdravilo Iscover je zaviralec agregacije trombocitov.
This means that it helps to prevent blood clots from forming.
To pomeni, da prispeva k preprečevanju nastajanja krvnih strdkov.
This stops the platelets becoming ‘ sticky’.
Klopidogrel, zdravilna učinkovina v zdravilu Iscover, zavira zlepljanje trombocitov tako, da onemogoča vezavo snovi ADP na posebni receptor na njihovi površini.
(44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged How has Iscover been studied?
(44- 20) 74 18 84 00 Fax (44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http: // www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Zaradi tega trombociti ne postanejo „ lepljivi “.
The effectiveness of Iscover as an anticoagulant was examined in a study (CAPRIE) of around 19,000 patients with atherothrombosis, where Iscover was compared with aspirin.
Učinkovitost zdravila Iscover kot antikoagulanta so preučevali v okviru študije (CAPRIE), ki je vključevala približno 19. 000 bolnikov z aterotrombozo, pri čemer so zdravilo Iscover primerjali z aspirinom.
Neither the patient nor the doctor knew what medicine the patient was receiving.
Ne bolnik ne zdravnik nista vedela, katero zdravilo bolnik prejema.
The study lasted from one to three years, and examined the rate of new ischaemic events (heart attacks, ischaemic strokes, and death).
Spremljanje posameznega bolnika je trajalo od enega do treh let, pri čemer je študija preučevala število novih ishemičnih dogodkov (srčnih napadov, ishemičnih kapi in smrti).
2,172 of these had a stent inserted during the study.
Pri zdravljenju akutnega koronarnega sindroma brez elevacije spojnice ST so zdravilo Iscover primerjali s placebom (zdravilom brez zdravilne učinkovine) pri več kot 12. 000 bolnikih, zdravljenih do enega leta (študija CURE), pri čemer je 2172 bolnikov med študijo imelo vstavljen stent.
In ST-elevation myocardial infarction, Iscover was compared with a placebo in two studies, CLARITY (over 3,000 patients, where the patients received Iscover for up to eight days) and COMMIT (almost 46,000 patients, where the patients received Iscover with or without metoprolol for up to four weeks).
Pri zdravljenju miokardnega infarkta z elevacijo spojnice ST so zdravilo Iscover primerjali s placebom v dveh študijah, CLARITY (ki je vključevala več kot 3000 bolnikov, ki so do osem dni prejemali zdravilo Iscover) in COMMIT (ki je vključevala skoraj 46. 000 bolnikov, ki so do štiri tedne prejemali zdravilo Iscover z ali brez metoprolola).
The studies looked at how many patients experienced an ‘ event’ such as a blocked artery, another heart attack or death, during the study.
V študijah so ugotavljali, koliko bolnikov je v času študije imelo „ dogodek “, kot je denimo zamašena arterija, nov srčni napad ali smrt.
What benefit has Iscover shown during the studies?
Kakšne koristi je zdravilo Iscover izkazalo med raziskavami?
There were 939 events in the Iscover group, and 1020 in the aspirin group.
V skupini, ki je prejemala Iscover, je bilo zabeleženih 939 dogodkov, v skupini, zdravljeni z aspirinom, pa 1020.
This corresponds to a relative reduction in risk of 8.7% compared to aspirin.
To ustreza relativnemu zmanjšanju tveganja za 8, 7% v primerjavi z aspirinom.
Risk reduction means that fewer patients will have new ischaemic events when they receive Iscover, than if they receive aspirin (in other words, about 10 patients in 1,000 will avoid having a new ischaemic event within two years of starting Iscover instead of aspirin).
Zmanjšanje tveganja pomeni, da bo manj bolnikov doživelo nov ishemični napad, če bodo prejemali zdravilo Iscover kot pa če bodo prejemali aspirin (z drugimi besedami, približno 10 bolnikov od 1000 se bo izognilo novemu ishemičnemu dogodku v dveh letih po pričetku jemanja zdravila Iscover namesto aspirina).
In non-ST elevation acute coronary syndrome, the overall relative reduction in the risk of an event compared to placebo was 20%.
Pri akutnem koronarnem sindromu brez elevacije spojnice ST je znašalo celotno relativno zmanjšanje tveganja za pojav dogodka v primerjavi s placebom 20%.
In ST-elevation myocardial infarction, fewer patients on Iscover had events than patients on placebo (262 against 377 in the CLARITY study, and 2,121 against 2,310 in the COMMIT study).
Pri miokardnem infarktu z elevacijo spojnice ST je bilo število bolnikov, pri katerih so se pojavili dogodki, manjše med bolniki, ki so jemali zdravilo Iscover, kot med bolniki, ki so prejemali placebo (262 v primerjavi s 377 v študiji CLARITY ter 2121 v primerjavi z 2310 v študiji COMMIT).
The main risk of Iscover is bleeding.
Glavno tveganje, povezano z zdravilom Iscover, so krvavitve.
Diarrhoea, abdominal pain and dyspepsia (indigestion or heartburn) are common (seen in between 1 and 10 patients in 100).
Driska, bolečina v trebuhu in dispepsija (slaba prebava ali zgaga) so pogoste (opažene pri 1 do 10 bolnikih od 100).
Other side effects are uncommon or rare.
Drugi neželeni učinki so občasni ali redki.
For the full list of all side effects reported with Iscover, see the Package Leaflet.
Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Iscover, glejte Navodilo za uporabo.